Small-Cap OS Therapies Inks Commercial Manufacture Agreements For Lead Cancer Drug For Rare Type Of Bone Cancer
OS Therapies, Inc. (NYSE-A: OSTX) entered into agreements for the commercial manufacture of OST-HER2. The company is ...
Armed robbery in Revesby21h
SETDB1 Amplification Eyed for Osteosarcoma Therapy
Our team has demonstrated the presence of SETDB1 abnormalities, particularly its amplification, through WES analysis of osteosarcoma human samples ...
OS Therapies gears up for FDA meeting on cancer drug
NEW YORK - OS Therapies, Inc. (NYSE-A: OSTX), a small-cap biotech firm with a market capitalization of $42 million focusing on cancer treatment solutions, has announced the completion of its Phase 2b ...
Le Lézard1d
OS Therapies Initiates Commercial-ready Manufacturing of OST-HER2 to Support Anticipated Biologics Licensing Authorization (BLA) Filing
OS Therapies, Inc. , a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it has entered into agreements for the ...
EurekAlert!1d
SETDB1 amplification identified as a potential target for new osteosarcoma treatment
A new review was published in Oncotarget, Volume 16, on February 12, 2025, titled “SETDB1 amplification in osteosarcomas: ...
WLKY2d
'Do it for Davo': Manual senior returns to the court while battling osteosarcoma
Davis Randle's teammates said the strength he's showed throughout the struggle of battling cancer has motivated them all season.
Genomics England3d
Researchers uncover a key driver of aggressive bone cancer
New research using data from the 100,000 Genomes Project has identified a genetic change that drives osteosarcoma, an ...
Boy, 9, befriended by actor dies from cancer
His story touched thousands when, in December last year, his dream of meeting actor Reynolds became a reality following an ...